Sentence examples for syntax score from inspiring English sources

However, among 144 patients with obstructive coronary artery disease, despite abnormal ABI being able to identify a higher rate of patients with B2 or C type lesions (70.9% versus 53.8%; P=0.039), the mean SYNTAX scores (13 versus 9; P=0.14), and the proportion of patients with SYNTAX score >16 (34.2% versus 27.7%; P=0.47), were similar, irrespective of ABI.

The SYNTAX score II aimed to overcome this limitation by considering clinical variables in addition to the anatomical SYNTAX score.

Circulating DcR3 levels and the Syntax score (SXscore) were determined in patients with multivessel CAD.

The residual SYNTAX score (rSS) was designed and validated to quantify the burden of residual coronary artery disease after percutaneous coronary intervention (PCI).

SYNTAX score was also significantly associated with BMP-2 (Spearman ρ = 0.46; p = 0.0002).

The SYNTAX score for each patient was calculated by a team of two interventional cardiologists.

In future, it may be advisable to focus similar studies only to the subgroup of patients with higher Syntax scores.

The number of lesions per patient, the number of patients with complex lesions, and the median SYNTAX scores were greater in the group with abnormal ABI.

Patients with low or intermediate SYNTAX scores in the CABG and in the PCI group had similar rates of major adverse cardiac or cerebrovascular events, whereas among patients with high scores (indicating more complex coronary anatomy), the event rate was significantly increased in the PCI group.

This effect size was conservatively based on Law's 2004 systematic review of the efficacy of treatment for children with developmental language delay, 20 in which the three included studies of parent delivered interventions yielded a pooled effect size of 0.83 (95% confidence interval −0.96 to 2.63) on preschool children's expressive syntax scores.

The SYNTAX (SX) score, an interesting tool to characterize the severity of the coronary artery disease was designed to predict cardiovascular outcomes in patients with three-vessel or unprotected left main coronary artery (ULMCA) disease in the SYNTAX study.